Patents

US 9764077 B2: Method for extracorporeal removal of pathogenic microbe, an inflammatory cell or an inflammatory protein from blood

Granted
2017-09-19
Filed
2015-10-01 application 14873133
Type
Utility · 6 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present invention relates to a method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from mammalian blood/use of a device comprising a carbohydrate immobilized on a solid substrate, said carbohydrate having a binding affinity for a pathogenic microbe, an inflammatory cell or an inflammatory protein, for extracorporeal removal of said pathogenic microbe, inflammatory cell or inflammatory protein from mammalian blood/use of a carbohydrate having a binding affinity for a pathogenic microbe, an inflammatory cell or an inflammatory protein, wherein said carbohydrate is immobilized on a solid substrate, in the preparation of a device for treatment of a condition caused or aggravated by said pathogenic microbe, inflammatory cell or inflammatory protein and a method for treatment of a mammalian subject suffering from a condition caused or aggravated by a pathogenic microbe, an inflammatory cell or an inflammatory protein.

Source: PVGPATDIS, file of 2026-04-10 (ipg170919.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
EXTHERA MEDICAL CORPORATION 22 patentsUS company or organizationMartinez, CAExThera Medical Corp Form D issuer FUZZY medium confidence: same name (legal endings aside) and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Olle LarmBromma, SE14PVGPATDIS, file of 2026-04-10
Tomas BergstromGothenburg, SE9PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61MDevices for introducing media into, or onto, the body ; devices for transducing body media or for taking media from the body ; devices for producing or ending sleep or stuporA61M1/3679PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K31/70PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P7/08PVGPATDIS, file of 2026-04-10
Y02ATechnologies for adaptation to climate changeY02A50/30PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2020-06-12Name change
Change of address
EXTHERA MEDICAL CORPORATION signed 2020-06-09EXTHERA MEDICAL CORPORATION MARTINEZ, CA52927/321ECORSEXC, file of 2026-09-25
2016-01-05Name change
Change of name
EXTHERA MEDICAL LLC signed 2010-12-31EXTHERA MEDICAL CORPORATION BERKELEY, CA37443/917ECORSEXC, file of 2026-09-25
2016-01-05Assignment
Assignment of assignor's interest
EXTHERA AB signed 2009-12-15EXTHERA MEDICAL LLC BERKELEY, CA37442/863ECORSEXC, file of 2026-09-25
2016-01-05Assignment
Assignment of assignor's interest
LARM, OLLE signed 2008-08-06
BERGSTROM, TOMAS signed 2008-08-08
EXTHERA AB STOCKHOLM37410/590ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.